Building An In-House Cell And Gene Therapy Manufacturing Facility During The Pandemic

By William Swaney, Expression Therapeutics and Dennis Powers, G-CON

This presentations discusses how the pandemic effected the timeline of this project, the challenges it presented, and project execution and results. Review a project between G-CON and Expressions Therapeutics that included a strategic vision for end to end control over CGT product manufacture, 43,000 square foot manufacturing facility and cleanrooms manufactured by G-CON. Results include a look at the Do's-and-Don'ts of project execution during the pandemic.